While donation-based crowdfunding has taken some industries, like consumer technology, by storm, it’s been dismissed by some as a source of early-stage life science funding because of the sky-high price tag that biotech and medical device R&D carries. Raising a few thousand dollars won’t really do much to get a company off the ground. But […]
Athersys (NYSE:ATHX) is looking to Japan for potential opportunities to bring its MultiStem therapies to market quicker. In its annual financial results call on Thursday, Athersys’ chief operating officer, BJ Lehmann, explained that legislation passed last fall in Japan could allow for conditional approval of new regenerative medicines that demonstrate strong safety profiles in clinical […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
It’s easy to look at Nobel Prize winners and assume the greatness of their work. But it’s even more awe-inspiring to understand the research and see it in action. This year, the Nobel Prize in physiology or medicine was given to regenerative medicine researchers Sir. John B. Gurdon of the University of Cambridge and Shinya […]
Imagine a man with a recent severe heart attack who has the muscle repaired with stem cells or a child with a severe bladder defect repaired with stem cells grown on a biodegradable scaffold. Sounds like science fiction but these are actual clinical studies in progress today. Stem cell therapies promise to be one of […]